Suppr超能文献

疟疾传播强度与恶性疟原虫耐药疟疾的传播:流行病学现场证据综述

Intensity of malaria transmission and the spread of Plasmodium falciparum resistant malaria: a review of epidemiologic field evidence.

作者信息

Talisuna Ambrose O, Okello Paul E, Erhart Annette, Coosemans Marc, D'Alessandro Umberto

机构信息

Uganda Ministry of Health, Epidemiological Surveillance Division, Kampala, Uganda.

出版信息

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):170-80.

Abstract

Malaria transmission intensity has been proposed, based on theoretical models, as an important factor for the spread of falciparum-resistant malaria, but the predictions obtained vary according to the assumptions inherent in the model used. We summarized the available field data on transmission intensity and the prevalence of malaria drug resistance. Resistance to chloroquine and sulphadoxine-pyrimethamine monotherapy was invariably higher where transmission was intense. Vector control interventions were associated with a better chloroquine and sulfadoxine-pyrimethamine efficacy. However, high resistance to chloroquine and also to combination therapy (chloroquine plus sulphadoxine-pyrimethamine and amodiaquine plus sulfadoxine-pyrimethamine) was also observed in very low transmission areas. Reducing transmission intensity is likely to slow the spread of drug resistance. Nevertheless, where transmission is extremely low, to limit the unnecessary use of antimalarials and a consequent paradoxical acceleration of the spread of resistance, patients should be treated only after laboratory confirmation of malaria.

摘要

基于理论模型,疟疾传播强度被认为是耐恶性疟传播的一个重要因素,但根据所使用模型的内在假设,得出的预测结果各不相同。我们总结了关于传播强度和疟疾耐药性流行情况的现有实地数据。在传播强烈的地区,对氯喹和磺胺多辛-乙胺嘧啶单一疗法的耐药性始终较高。病媒控制干预措施与氯喹和磺胺多辛-乙胺嘧啶的疗效较好相关。然而,在传播极低的地区也观察到对氯喹以及联合疗法(氯喹加磺胺多辛-乙胺嘧啶和阿莫地喹加磺胺多辛-乙胺嘧啶)的高耐药性。降低传播强度可能会减缓耐药性的传播。然而,在传播极其低的地区,为了限制抗疟药的不必要使用以及由此导致的耐药性传播的矛盾加速,患者应仅在实验室确诊疟疾后才进行治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验